carmustine has been researched along with losartan potassium in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (36.36) | 18.7374 |
1990's | 3 (27.27) | 18.2507 |
2000's | 2 (18.18) | 29.6817 |
2010's | 2 (18.18) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Reissmann, KR; Udupa, KB | 1 |
Kawada, K; Reissmann, KR; Udupa, KB | 1 |
Koury, MJ; Krantz, SB | 1 |
Kreja, L; Seidel, HJ | 1 |
Daguenel, A; Gorin, NC; Laporte, JP; Lesage, S; Najman, A; Parlier, Y; Woler, M | 1 |
Peters, WP; Petros, WP; Rabinowitz, J; Stuart, AR | 1 |
Donovan, C; Dumenco, LL; Gerson, SL; Kastan, M; Phillips, W | 1 |
Blaise, D; Caraux, J; Chabannon, C; Faucher, C; Maraninchi, D; Vey, N | 1 |
Cailliot, C; Fouillard, L; Gorin, NC; Isnard, F; Labopin, M; Laporte, JP; Lesage, S; Najman, A; Yeshurun, M | 1 |
Ford, PA; Grant, SJ; Keck, G; Mick, R | 1 |
1 trial(s) available for carmustine and losartan potassium
Article | Year |
---|---|
Characterization of endogenous cytokine concentrations after high-dose chemotherapy with autologous bone marrow support.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytokines; Enzyme-Linked Immunosorbent Assay; Erythropoietin; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interleukin-6; Kinetics; Macrophage Colony-Stimulating Factor; Melanoma; Neoplasm Staging; Recombinant Proteins; Transplantation, Autologous; Tumor Necrosis Factor-alpha | 1993 |
10 other study(ies) available for carmustine and losartan potassium
Article | Year |
---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
In vivo erythropoietin requirements of regenerating erythroid progenitors (BFU-e, CFU-e) in bone marrow of mice.
Topics: Animals; Bone Marrow Cells; Busulfan; Carmustine; Erythrocytes; Erythropoiesis; Erythropoietin; Female; Hematopoietic Stem Cells; Mice; Polycythemia | 1979 |
Effects of erythropoietin and androgens on erythroid stem cells after their selective suppression by BCNU.
Topics: Animals; Bone Marrow; Bone Marrow Cells; Carmustine; Cell Division; Erythrocyte Aging; Erythropoiesis; Erythropoietin; Female; Hematopoiesis; Hematopoietic Stem Cells; Hypoxia; Iron; Iron Radioisotopes; Mice; Nandrolone; Neutrophils; Polycythemia; Propylene Glycols; Radiation Chimera; Spleen; Testosterone | 1974 |
Velocity sedimentation profiles of normal and regenerating primitive erythroid burst-forming units: relation to phase of cell cycle and growth in vitro.
Topics: Animals; Carmustine; Cell Cycle; Cell Separation; Centrifugation, Density Gradient; DNA; Erythropoiesis; Erythropoietin; Hematopoietic Stem Cells; Hydroxyurea; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Regeneration | 1982 |
Hematopoietic stem cells in Friend murine leukemia virus infected mice undergoing chemotherapy: failure to eradicate Ep-independent erythropoiesis by BCNU.
Topics: Animals; Bone Marrow Cells; Carmustine; Cell Differentiation; Colony-Forming Units Assay; Erythropoiesis; Erythropoietin; Female; Friend murine leukemia virus; Hematopoietic Stem Cells; Leukemia, Experimental; Mice; Mice, Inbred DBA; Organ Size; Reticulocytes; Spleen | 1982 |
Administration of three cytokines instead of bone marrow transplantation in an HIV+ patient with high-grade lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cyclophosphamide; Cytarabine; Cytokines; Doxorubicin; Drug Therapy, Combination; Erythropoietin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lymphoma, AIDS-Related; Melphalan; Prednisolone; Vincristine | 1994 |
Human CD34+ hematopoietic progenitors have low, cytokine-unresponsive O6-alkylguanine-DNA alkyltransferase and are sensitive to O6-benzylguanine plus BCNU.
Topics: Adult; Antigens, CD34; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Bone Marrow Cells; Carmustine; Cells, Cultured; Colony-Forming Units Assay; Culture Media, Conditioned; DNA Damage; DNA Repair; Drug Resistance; Drug Synergism; Enzyme Inhibitors; Erythropoietin; Granulocyte-Macrophage Colony-Stimulating Factor; Guanine; Hematopoietic Stem Cells; Humans; Interleukin-3; Methyltransferases; O(6)-Methylguanine-DNA Methyltransferase; Recombinant Proteins; Stem Cell Factor | 1996 |
Rescue of haemopoiesis by a combination of growth factors including stem-cell factor.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carmustine; Cytarabine; Epoetin Alfa; Erythrocyte Transfusion; Erythropoietin; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoiesis; Hematopoietic Cell Growth Factors; Humans; Lymphoma, Non-Hodgkin; Melphalan; Platelet Transfusion; Recombinant Proteins; Treatment Outcome | 2000 |
A long-term follow-up of 33 patients with non-Hodgkin's lymphoma who received the BEAM high-dose intensification regimen with cytokine support only and no transplant.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cytarabine; Drug Therapy, Combination; Erythropoietin; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Survival Rate; Time Factors | 2004 |
Autologous Stem-Cell Transplantation Without Hematopoietic Support for the Treatment of Hematologic Malignancies in Jehovah's Witnesses.
Topics: Adult; Aged; Aminocaproic Acid; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Carmustine; Combined Modality Therapy; Cyclophosphamide; Erythropoietin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hematologic Neoplasms; Hemoglobins; Humans; Iron; Jehovah's Witnesses; Lymphoma; Male; Melphalan; Middle Aged; Multiple Myeloma; Recurrence; Stem Cell Transplantation; Transplantation, Autologous; Vitamin K 1; Young Adult | 2015 |